Global Peptide Therapeutics Market Professional Survey Report 2016

November 2016 | 116 pages | ID: G4AFFF516C9EN
QYResearch

Abstracts

Notes:

Production, means the output of Peptide Therapeutics

Revenue, means the sales value of Peptide Therapeutics

This report studies Peptide Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Amgen
• Roche
• Sanofi
• Takeda Pharmaceutical
• Lonza
• Novartis
• AstraZeneca
• Bachem
• CordenPharma
• Eli Lilly
• Ipsen
• Merck
• Novo Nordisk
• PolyPeptide Group
• Teva

By types, the market can be split into

• Generic Peptide Therapeutics
• Branded Peptide Therapeutics
• Type III

By Application, the market can be split into

• Cancer
• Cardiovascular
• Central Nervous System
• Metabolic Disorders
• Infection
• Hematological Disorders
• Gastrointestinal Disorders
• Respiratory Disorders
• Acromegaly
• Other Applications

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

Contents

Global Peptide Therapeutics Market Professional Survey Report 2016

1 INDUSTRY OVERVIEW OF PEPTIDE THERAPEUTICS

1.1 Definition and Specifications of Peptide Therapeutics
  1.1.1 Definition of Peptide Therapeutics
  1.1.2 Specifications of Peptide Therapeutics
1.2 Classification of Peptide Therapeutics
  1.2.1 Generic Peptide Therapeutics
  1.2.2 Branded Peptide Therapeutics
  1.2.3 Type III
1.3 Applications of Peptide Therapeutics
  1.3.1 Cancer
  1.3.2 Cardiovascular
  1.3.3 Central Nervous System
  1.3.4 Metabolic Disorders
  1.3.5 Infection
  1.3.6 Hematological Disorders
  1.3.7 Gastrointestinal Disorders
  1.3.8 Respiratory Disorders
  1.3.9 Acromegaly
  1.3.10 Other Applications
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PEPTIDE THERAPEUTICS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Peptide Therapeutics
2.3 Manufacturing Process Analysis of Peptide Therapeutics
2.4 Industry Chain Structure of Peptide Therapeutics

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PEPTIDE THERAPEUTICS

3.1 Capacity and Commercial Production Date of Global Peptide Therapeutics Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Peptide Therapeutics Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Peptide Therapeutics Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Peptide Therapeutics Major Manufacturers in 2015

4 GLOBAL PEPTIDE THERAPEUTICS OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2011-2016E Global Peptide Therapeutics Capacity and Growth Rate Analysis
  4.2.2 2015 Peptide Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2016E Global Peptide Therapeutics Sales and Growth Rate Analysis
  4.3.2 2015 Peptide Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2016E Global Peptide Therapeutics Sales Price
  4.4.2 2015 Peptide Therapeutics Sales Price Analysis (Company Segment)

5 PEPTIDE THERAPEUTICS REGIONAL MARKET ANALYSIS

5.1 North America Peptide Therapeutics Market Analysis
  5.1.1 North America Peptide Therapeutics Market Overview
  5.1.2 North America 2011-2016E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Peptide Therapeutics Sales Price Analysis
  5.1.4 North America 2015 Peptide Therapeutics Market Share Analysis
5.2 China Peptide Therapeutics Market Analysis
  5.2.1 China Peptide Therapeutics Market Overview
  5.2.2 China 2011-2016E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2011-2016E Peptide Therapeutics Sales Price Analysis
  5.2.4 China 2015 Peptide Therapeutics Market Share Analysis
5.3 Europe Peptide Therapeutics Market Analysis
  5.3.1 Europe Peptide Therapeutics Market Overview
  5.3.2 Europe 2011-2016E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2011-2016E Peptide Therapeutics Sales Price Analysis
  5.3.4 Europe 2015 Peptide Therapeutics Market Share Analysis
5.4 Southeast Asia Peptide Therapeutics Market Analysis
  5.4.1 Southeast Asia Peptide Therapeutics Market Overview
  5.4.2 Southeast Asia 2011-2016E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2011-2016E Peptide Therapeutics Sales Price Analysis
  5.4.4 Southeast Asia 2015 Peptide Therapeutics Market Share Analysis
5.5 Japan Peptide Therapeutics Market Analysis
  5.5.1 Japan Peptide Therapeutics Market Overview
  5.5.2 Japan 2011-2016E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2011-2016E Peptide Therapeutics Sales Price Analysis
  5.5.4 Japan 2015 Peptide Therapeutics Market Share Analysis
5.6 India Peptide Therapeutics Market Analysis
  5.6.1 India Peptide Therapeutics Market Overview
  5.6.2 India 2011-2016E Peptide Therapeutics Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Peptide Therapeutics Sales Price Analysis
  5.6.4 India 2015 Peptide Therapeutics Market Share Analysis

6 GLOBAL 2011-2016E PEPTIDE THERAPEUTICS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Peptide Therapeutics Sales by Type
6.2 Different Types of Peptide Therapeutics Product Interview Price Analysis
6.3 Different Types of Peptide Therapeutics Product Driving Factors Analysis
  6.3.1 Generic Peptide Therapeutics of Peptide Therapeutics Growth Driving Factor Analysis
  6.3.2 Branded Peptide Therapeutics of Peptide Therapeutics Growth Driving Factor Analysis
  6.3.3 Type III Peptide Therapeutics Growth Driving Factor Analysis

7 GLOBAL 2011-2016E PEPTIDE THERAPEUTICS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Peptide Therapeutics Consumption by Application
7.2 Different Application of Peptide Therapeutics Product Interview Price Analysis
7.3 Different Application of Peptide Therapeutics Product Driving Factors Analysis
  7.3.1 Cancer of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.2 Cardiovascular of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.3 Central Nervous System of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.4 Metabolic Disorders of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.5 Infection of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.6 Hematological Disorders of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.7 Gastrointestinal Disorders of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.8 Respiratory Disorders of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.9 Acromegaly of Peptide Therapeutics Growth Driving Factor Analysis
  7.3.10 Other Applications of Peptide Therapeutics Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PEPTIDE THERAPEUTICS

8.1 Amgen
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Type I
    8.1.2.2 Type II
    8.1.2.3 Type III
  8.1.3 Amgen 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Amgen 2015 Peptide Therapeutics Business Region Distribution Analysis
8.2 Roche
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Type I
    8.2.2.2 Type II
    8.2.2.3 Type III
  8.2.3 Roche 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Roche 2015 Peptide Therapeutics Business Region Distribution Analysis
8.3 Sanofi
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Type I
    8.3.2.2 Type II
    8.3.2.3 Type III
  8.3.3 Sanofi 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Sanofi 2015 Peptide Therapeutics Business Region Distribution Analysis
8.4 Takeda Pharmaceutical
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Type I
    8.4.2.2 Type II
    8.4.2.3 Type III
  8.4.3 Takeda Pharmaceutical 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Takeda Pharmaceutical 2015 Peptide Therapeutics Business Region Distribution Analysis
8.5 Lonza
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Type I
    8.5.2.2 Type II
    8.5.2.3 Type III
  8.5.3 Lonza 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Lonza 2015 Peptide Therapeutics Business Region Distribution Analysis
8.6 Novartis
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Type I
    8.6.2.2 Type II
    8.6.2.3 Type III
  8.6.3 Novartis 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Novartis 2015 Peptide Therapeutics Business Region Distribution Analysis
8.7 AstraZeneca
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Type I
    8.7.2.2 Type II
    8.7.2.3 Type III
  8.7.3 AstraZeneca 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 AstraZeneca 2015 Peptide Therapeutics Business Region Distribution Analysis
8.8 Bachem
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Type I
    8.8.2.2 Type II
    8.8.2.3 Type III
  8.8.3 Bachem 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Bachem 2015 Peptide Therapeutics Business Region Distribution Analysis
8.9 CordenPharma
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Type I
    8.9.2.2 Type II
    8.9.2.3 Type III
  8.9.3 CordenPharma 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 CordenPharma 2015 Peptide Therapeutics Business Region Distribution Analysis
8.10 Eli Lilly
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Type I
    8.10.2.2 Type II
    8.10.2.3 Type III
  8.10.3 Eli Lilly 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Eli Lilly 2015 Peptide Therapeutics Business Region Distribution Analysis
8.11 Ipsen
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
    8.11.2.1 Type I
    8.11.2.2 Type II
    8.11.2.3 Type III
  8.11.3 Ipsen 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 Ipsen 2015 Peptide Therapeutics Business Region Distribution Analysis
8.12 Merck
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
    8.12.2.1 Type I
    8.12.2.2 Type II
    8.12.2.3 Type III
  8.12.3 Merck 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.12.4 Merck 2015 Peptide Therapeutics Business Region Distribution Analysis
8.13 Novo Nordisk
  8.13.1 Company Profile
  8.13.2 Product Picture and Specifications
    8.13.2.1 Type I
    8.13.2.2 Type II
    8.13.2.3 Type III
  8.13.3 Novo Nordisk 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.13.4 Novo Nordisk 2015 Peptide Therapeutics Business Region Distribution Analysis
8.14 PolyPeptide Group
  8.14.1 Company Profile
  8.14.2 Product Picture and Specifications
    8.14.2.1 Type I
    8.14.2.2 Type II
    8.14.2.3 Type III
  8.14.3 PolyPeptide Group 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.14.4 PolyPeptide Group 2015 Peptide Therapeutics Business Region Distribution Analysis
8.15 Teva
  8.15.1 Company Profile
  8.15.2 Product Picture and Specifications
    8.15.2.1 Type I
    8.15.2.2 Type II
    8.15.2.3 Type III
  8.15.3 Teva 2015 Peptide Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.15.4 Teva 2015 Peptide Therapeutics Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF PEPTIDE THERAPEUTICS MARKET

9.1 Global Peptide Therapeutics Market Trend Analysis
  9.1.1 Global 2016-2021 Peptide Therapeutics Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Peptide Therapeutics Sales Price Forecast
9.2 Peptide Therapeutics Regional Market Trend
  9.2.1 North America 2016-2021 Peptide Therapeutics Consumption Forecast
  9.2.2 China 2016-2021 Peptide Therapeutics Consumption Forecast
  9.2.3 Europe 2016-2021 Peptide Therapeutics Consumption Forecast
  9.2.4 Southeast Asia 2016-2021 Peptide Therapeutics Consumption Forecast
  9.2.5 Japan 2016-2021 Peptide Therapeutics Consumption Forecast
  9.2.6 India 2016-2021 Peptide Therapeutics Consumption Forecast
9.3 Peptide Therapeutics Market Trend (Product Type)
9.4 Peptide Therapeutics Market Trend (Application)

10 PEPTIDE THERAPEUTICS MARKETING TYPE ANALYSIS

10.1 Peptide Therapeutics Regional Marketing Type Analysis
10.2 Peptide Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Peptide Therapeutics by Regions
10.4 Peptide Therapeutics Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PEPTIDE THERAPEUTICS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL PEPTIDE THERAPEUTICS MARKET PROFESSIONAL SURVEY REPORT 2016

Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Peptide Therapeutics
Table Product Specifications of Peptide Therapeutics
Table Classification of Peptide Therapeutics
Figure Global Production Market Share of Peptide Therapeutics by Type in 2015
Figure Generic Peptide Therapeutics Picture
Table Major Manufacturers of Generic Peptide Therapeutics
Figure Branded Peptide Therapeutics Picture
Table Major Manufacturers of Branded Peptide Therapeutics
Table Applications of Peptide Therapeutics
Figure Global Consumption Volume Market Share of Peptide Therapeutics by Application in 2015
Figure Cancer Examples
Table Major Consumers of Cancer
Figure Cardiovascular Examples
Table Major Consumers of Cardiovascular
Figure Central Nervous System Examples
Table Major Consumers of Central Nervous System
Figure Metabolic Disorders Examples
Table Major Consumers of Metabolic Disorders
Figure Infection Examples
Table Major Consumers of Infection
Figure Hematological Disorders Examples
Table Major Consumers of Hematological Disorders
Figure Gastrointestinal Disorders Examples
Table Major Consumers of Gastrointestinal Disorders
Figure Respiratory Disorders Examples
Table Major Consumers of Respiratory Disorders
Figure Acromegaly Examples
Table Major Consumers of Acromegaly
Figure Other Applications Examples
Table Major Consumers of Other Applications
Figure Market Share of Peptide Therapeutics by Regions
Figure North America Peptide Therapeutics Market Size (2011-2021)
Figure China Peptide Therapeutics Market Size (2011-2021)
Figure Europe Peptide Therapeutics Market Size (2011-2021)
Figure Southeast Asia Peptide Therapeutics Market Size (2011-2021)
Figure Japan Peptide Therapeutics Market Size (2011-2021)
Figure India Peptide Therapeutics Market Size (2011-2021)
Table Peptide Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Peptide Therapeutics in 2015
Figure Manufacturing Process Analysis of Peptide Therapeutics
Figure Industry Chain Structure of Peptide Therapeutics
Table Capacity (K MT) and Commercial Production Date of Global Peptide Therapeutics Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Peptide Therapeutics Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Peptide Therapeutics Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Peptide Therapeutics Major Manufacturers in 2015
Table Global Capacity (K MT), Sales (K MT), Price (USD/MT), Cost (USD/MT), Sales Revenue (M USD) and Gross Margin of Peptide Therapeutics 2011-2016
Figure Global 2011-2016E Peptide Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Peptide Therapeutics Market Size (Value) and Growth Rate
Table 2011-2016E Global Peptide Therapeutics Capacity and Growth Rate
Table 2015 Global Peptide Therapeutics Capacity List (Company Segment)
Table 2011-2016E Global Peptide Therapeutics Sales and Growth Rate
Table 2015 Global Peptide Therapeutics Sales List (Company Segment)
Table 2011-2016E Global Peptide Therapeutics Sales Price
Table 2015 Global Peptide Therapeutics Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Peptide Therapeutics 2011-2016 (K MT)
Figure North America 2011-2016E Peptide Therapeutics Sales Price (USD/MT)
Figure North America 2015 Peptide Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Peptide Therapeutics 2011-2016 (K MT)
Figure China 2011-2016E Peptide Therapeutics Sales Price (USD/MT)
Figure China 2015 Peptide Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Peptide Therapeutics 2011-2016 (K MT)
Figure Europe 2011-2016E Peptide Therapeutics Sales Price (USD/MT)
Figure Europe 2015 Peptide Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Peptide Therapeutics 2011-2016 (K MT)
Figure Southeast Asia 2011-2016E Peptide Therapeutics Sales Price (USD/MT)
Figure Southeast Asia 2015 Peptide Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Peptide Therapeutics 2011-2016 (K MT)
Figure Japan 2011-2016E Peptide Therapeutics Sales Price (USD/MT)
Figure Japan 2015 Peptide Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Peptide Therapeutics 2011-2016 (K MT)
Figure India 2011-2016E Peptide Therapeutics Sales Price (USD/MT)
Figure India 2015 Peptide Therapeutics Sales Market Share
Table Global 2011-2016E Peptide Therapeutics Sales by Type
Table Different Types Peptide Therapeutics Product Interview Price
Table Global 2011-2016E Peptide Therapeutics Sales by Application
Table Different Application Peptide Therapeutics Product Interview Price
Table Amgen Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Amgen Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Amgen 2015 Peptide Therapeutics Business Region Distribution
Table Roche Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Roche Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Roche 2015 Peptide Therapeutics Business Region Distribution
Table Sanofi Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Sanofi Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Sanofi 2015 Peptide Therapeutics Business Region Distribution
Table Takeda Pharmaceutical Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Takeda Pharmaceutical Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Takeda Pharmaceutical 2015 Peptide Therapeutics Business Region Distribution
Table Lonza Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Lonza Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Lonza 2015 Peptide Therapeutics Business Region Distribution
Table Novartis Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Novartis Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Novartis 2015 Peptide Therapeutics Business Region Distribution
Table AstraZeneca Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 AstraZeneca Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 AstraZeneca 2015 Peptide Therapeutics Business Region Distribution
Table Bachem Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Bachem Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Bachem 2015 Peptide Therapeutics Business Region Distribution
Table CordenPharma Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 CordenPharma Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 CordenPharma 2015 Peptide Therapeutics Business Region Distribution
Table Eli Lilly Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Eli Lilly Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Eli Lilly 2015 Peptide Therapeutics Business Region Distribution
Table Ipsen Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Ipsen Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Ipsen 2015 Peptide Therapeutics Business Region Distribution
Table Merck Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Merck Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Merck 2015 Peptide Therapeutics Business Region Distribution
Table Novo Nordisk Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Novo Nordisk Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Novo Nordisk 2015 Peptide Therapeutics Business Region Distribution
Table PolyPeptide Group Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 PolyPeptide Group Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 PolyPeptide Group 2015 Peptide Therapeutics Business Region Distribution
Table Teva Information List
Table Type I Peptide Therapeutics Overview
Table Type II Peptide Therapeutics Overview
Table Type III Peptide Therapeutics Overview
Table 2015 Teva Peptide Therapeutics Revenue, Sales, Ex-factory Price
Figure 2015 Teva 2015 Peptide Therapeutics Business Region Distribution
Figure Global 2016-2021 Peptide Therapeutics Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Peptide Therapeutics Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Peptide Therapeutics Sales Price (USD/MT) Forecast
Figure North America 2016-2021 Peptide Therapeutics Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Peptide Therapeutics Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Peptide Therapeutics Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Peptide Therapeutics Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Peptide Therapeutics Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Peptide Therapeutics Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K MT) of Peptide Therapeutics by Types 2016-2021
Table Global Consumption Volume (K MT) of Peptide Therapeutics by Applications 2016-2021
Table Traders or Distributors with Contact Information of Peptide Therapeutics by Regions
Table Part of Interviewees Record List